Work

Levetiracetam Induced Acute Reversible Psychosis: A Case Report

Year: 2024

Type: article

Abstract: Levetiracetam (Keppra) is a second-generation antiepileptic drug (AED) widely used for focal and generalized seizures due to its efficacy, favourable pharmacokinetics, and low risk of drug interactions.However, its neuropsychiatric side effects, including aggression, mood disturbances, and psychosis, are increasingly recognized.Keppra-induced psychosis (KIP) is a rare but serious adverse effect that can significantly impact patient safety and treatment adherence.While psychiatric symptoms associated with levetiracetam use have been described, reports of psychosis remain relatively uncommon.We present a case of Keppra-induced psychosis in a patient with no prior psychiatric history, emphasizing the importance of recognizing this rare but serious adverse effect.

Source: Annals of Case Reports

DOI: 10.29011/2574-7754.102227

Authors: Aneeta Regi, Aneeta Regi, Adeel Hussain, Albert Regi, Albert Regi, Bethan Davies

Institutions: Royal College of Surgeons in Ireland, University College Cork, Hywel Dda University Health Board

Language: English

Topic: Epilepsy research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4408955234